Phylogica's CFO & VP Corporate Development, Nick Woolf was interviewed by the Finances News Network about their recent project milestone with Pfizer. The peptide drug discovery company and Pfizer collaboration started back in December 2010. The partnership seems to be proving to be a very successful one with Phylogica already received a payment for successfully completing the first stage of the collaboration in December 2011 and now another payment for reaching this new milestone. Phylogica continues to flourish with a fourth collaboration with Janseen, their largest yet financially. Phylogica is also in talk with new collaborating partners such as AstraZeneca and Roche for future projects.
To hear more from the interview with Nick Woolf click here
Nick Woolfe will be a Speaker at this year's BioPharma Australasia convention talking in the Drug Discovery and Developments module. To see how you can attend click here